10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001615774-16-004671`
Period End Date	20151231
Filing Date	20160329
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	heb-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 54 Cash Flow Statement 95 Stockholders Equity 20

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$13.95M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$6.79M	USD	Point-in-time
Work in process inventory	`InventoryWorkInProcess`	-	USD	Point-in-time
Work in process inventory	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Work in process inventory	`InventoryWorkInProcess`	$1.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$335.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$399.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.57M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	247.56M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	204.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.51M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.24M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.60M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	204.00M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	247.56M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$862.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$861.00K	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.34M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$29.44M	USD	Point-in-time
Total assets	`Assets`	$22.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.08M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.33M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$1.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$22.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.43M	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14 and 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14 and 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 247,559,487 and 204,004,818, respectively	`CommonStockValue`	$204.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 247,559,487 and 204,004,818, respectively	`CommonStockValue`	$247.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$302.73M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$313.22M	USD	Point-in-time
Unrealized loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-160.00K	USD	Point-in-time
Unrealized loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-97.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-277.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-293.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$29.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$44.70M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$29.44M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.80M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`HealthCareOrganizationRevenue`	$133.00K	USD	Annual
Clinical treatment programs	`HealthCareOrganizationRevenue`	$150.00K	USD	Annual
Clinical treatment programs	`HealthCareOrganizationRevenue`	$197.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$150.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$197.00K	USD	Annual
Total Revenues	`SalesRevenueNet`	$133.00K	USD	Annual
Production costs	`ManufacturingCosts`	$1.25M	USD	Annual
Production costs	`ManufacturingCosts`	$1.23M	USD	Annual
Production costs	`ManufacturingCosts`	$1.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.99M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.36M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.72M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.15M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$9.06M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$17.32M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$19.30M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$16.78M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-17.17M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.10M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-16.65M	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$364.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$665.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$791.00K	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$800.00K	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$145.00K	USD	Annual
Impairment loss on investments	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$315.00K	USD	Annual
Interest expense	`InterestExpense`	$11.00K	USD	Annual
Interest expense	`InterestExpense`	$16.00K	USD	Annual
Interest expense	`InterestExpense`	$3.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-686.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.13M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-1.37M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-281.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-14.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-15.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-16.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.45M	USD	Annual
Unrealized loss on securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-252.00K	USD	Annual
Unrealized loss on securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-191.00K	USD	Annual
Unrealized loss on securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-871.00K	USD	Annual
Reclassification adjustments for impairment losses on investments included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$145.00K	USD	Annual
Reclassification adjustments for impairment losses on investments included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$315.00K	USD	Annual
Reclassification adjustments for impairment losses on investments included in net loss	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$800.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.17M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.50M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.30M	USD	Annual
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	Annual
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	Annual
Basic and diluted loss per share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	Annual
Weighted average shares outstanding basic and diluted (in share)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	188.29M	shares	Annual
Weighted average shares outstanding basic and diluted (in share)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.33M	shares	Annual
Weighted average shares outstanding basic and diluted (in share)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	236.15M	shares	Annual

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-15.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-16.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.45M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$941.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$665.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$671.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$249.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$477.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$196.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-281.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-14.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$181.00K	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$376.00K	USD	Annual
Equity-based compensation	`StockOptionPlanExpense`	$326.00K	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$800.00K	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$145.00K	USD	Annual
Other-than-temporary impairment of marketable securities	`OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities`	$315.00K	USD	Annual
Unrealized gain on securities	`UnrealizedGainOnSecurities`	$46.00K	USD	Annual
Unrealized gain on securities	`UnrealizedGainOnSecurities`	$71.00K	USD	Annual
Unrealized gain on securities	`UnrealizedGainOnSecurities`	$-63.00K	USD	Annual
Inventory reserve	`InventoryLIFOReserveEffectOnIncomeNet`	$453.00K	USD	Annual
Inventory reserve	`InventoryLIFOReserveEffectOnIncomeNet`	-	USD	Annual
Inventory reserve	`InventoryLIFOReserveEffectOnIncomeNet`	-	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.33M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$41.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$36.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-64.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-196.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-617.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$869.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.17M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.11M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.10M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-16.05M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-16.90M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-13.96M	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$504.00K	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$240.00K	USD	Annual
Purchases of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$898.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$258.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$242.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$250.00K	USD	Annual
Office rental deposit	`OfficeRentalDeposit`	-	USD	Annual
Office rental deposit	`OfficeRentalDeposit`	$71.00K	USD	Annual
Office rental deposit	`OfficeRentalDeposit`	-	USD	Annual
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	-	USD	Annual
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	-	USD	Annual
Deposits on capital leases refunded	`DepositsOnCapitalLeasesRefunded`	$2.00K	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$23.55M	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$6.84M	USD	Annual
Sales and maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$3.29M	USD	Annual
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	Annual
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	Annual
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$6.35M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.53M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$22.34M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$12.82M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$249.00K	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$9.68M	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$34.00K	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$45.00K	USD	Annual
Payments on capital leases	`PaymentsOnCapitalLeases`	$21.00K	USD	Annual
Payments on Margin Account Loan	`ProceedsPaymentFromMarginAccountLoan`	$7.05M	USD	Annual
Payments on Margin Account Loan	`ProceedsPaymentFromMarginAccountLoan`	-	USD	Annual
Payments on Margin Account Loan	`ProceedsPaymentFromMarginAccountLoan`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.66M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-6.85M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.78M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.35M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-41.00K	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.41M	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`LiabilitiesAssumed1`	$672.00K	USD	Annual
Issuance of common stock for accounts payable and accrued expenses	`LiabilitiesAssumed1`	$269.00K	USD	Annual
Issuance of common stock for accounts payable and accrued expenses	`LiabilitiesAssumed1`	$59.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$63.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$-46.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnSecurities`	$-71.00K	USD	Annual
Capitalized construction interest	`InterestPaidCapitalized`	-	USD	Annual
Capitalized construction interest	`InterestPaidCapitalized`	-	USD	Annual
Capitalized construction interest	`InterestPaidCapitalized`	$143.00K	USD	Annual
Cash paid for interest expense	`InterestPaid`	$11.00K	USD	Annual
Cash paid for interest expense	`InterestPaid`	$3.00K	USD	Annual
Cash paid for interest expense	`InterestPaid`	$16.00K	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$25.00M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$29.30M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$44.70M	USD	Point-in-time
Settlement of accounts payable	`StockIssuedDuringPeriodValueSettlementOfAccountsPayable`	$59.00K	USD	Annual
Settlement of accounts payable	`StockIssuedDuringPeriodValueSettlementOfAccountsPayable`	$672.00K	USD	Annual
Settlement of accounts payable	`StockIssuedDuringPeriodValueSettlementOfAccountsPayable`	$269.00K	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$249.00K	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$9.68M	USD	Annual
Shares sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$12.82M	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$181.00K	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$376.00K	USD	Annual
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$326.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.17M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.50M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.30M	USD	Annual
Balance, at end	`StockholdersEquity`	$25.00M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$29.30M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$20.37M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$44.70M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.